Correlation Between Madrigal Pharmaceuticals and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Apellis Pharmaceuticals.
Diversification Opportunities for Madrigal Pharmaceuticals and Apellis Pharmaceuticals
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Madrigal and Apellis is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Apellis Pharmaceuticals
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.7 times more return on investment than Apellis Pharmaceuticals. However, Madrigal Pharmaceuticals is 1.7 times more volatile than Apellis Pharmaceuticals. It trades about 0.34 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.19 per unit of risk. If you would invest 21,700 in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 12,818 from holding Madrigal Pharmaceuticals or generate 59.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Apellis Pharmaceuticals |
Madrigal Pharmaceuticals and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Apellis Pharmaceuticals
The main advantage of trading using opposite Madrigal Pharmaceuticals and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals |
| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |